Neumología

EPOC

Triple inhaler therapy optimization, bronchoscopic lung volume reduction (Zephyr valves), and pulmonary rehab.

Opciones de Tratamiento

Centros Recomendados

$14,000

Desde

7-21 días

Espera Típica

Planes de Tratamiento para EPOC

Compare opciones basadas en evidencia en los principales hospitales chinos — precios transparentes, tiempos de espera y recuperación.

Plan Principal

Bronchoscopic Lung Volume Reduction (Zephyr)

Endobronchial valve placement for severe emphysema with hyperinflation.

Tiempo de Espera

14-21 days

Estancia Hospitalaria

5-7 days

Recuperación

4-6 weeks

Precio Estimado

Approx. $18,000

Ver Introducción Detallada — Procedimiento, Comparación de Precios y Más

Comparación de Precios: China vs EE.UU.

🇨🇳 China

$14,000

🇺🇸 EE.UU.

$62,500+

Ahorre hasta $48,500 por tratamiento

Pasos del Procedimiento

Pre-op: HRCT chest + perfusion scan + 6MWT + fissure integrity assessment (Chartis)

Conscious sedation + local anesthetic spray to airway

Flexible bronchoscopy with target lobe identification

Chartis catheter assessment of collateral ventilation (CV-)

Sequential Zephyr valve deployment (3-5 valves per lobe)

Post-procedure observation for pneumothorax (highest risk Day 1-3)

Discharge Day 3-5 with chest X-ray monitoring

Pulmonary rehabilitation 6 weeks post-procedure

What are Zephyr Endobronchial Valves?

One-way valves placed bronchoscopically into the most diseased lobe of an emphysema lung, blocking inhaled air while allowing trapped air to escape. The hyperinflated lobe deflates, allowing healthier lobes to expand — essentially a non-surgical lung volume reduction.

Why China?

Cost: $25,000-$38,000 vs. $50,000-$90,000 in the US
NMPA approved: Pulmonx Zephyr valves available at top respiratory centers
No surgery: Bronchoscopic procedure, 3-5 day hospital stay
Reversible: Valves can be removed if needed

Who is a candidate?

Severe emphysema with hyperinflation (RV ≥175%, FEV1 15-50%)
Heterogeneous emphysema distribution
Intact interlobar fissures (CV-negative on Chartis)
Optimized medical therapy + pulmonary rehab

Outcomes

FEV1 improvement: 18-25%. 6MWT improvement: 30-40m. SGRQ quality of life improvement: clinically significant in 60-70%. Pneumothorax: 25-35% (most resolved with chest tube).

Reservar Consulta Gratuita WhatsApp

Los precios son rangos indicativos en USD basados en tarifas publicadas. La cotización final depende de sus registros médicos y hospital seleccionado — solicite una estimación personalizada gratuita.